UB Paderborn / Katalog / Suche / in CDI

1 – 15 von 15

Sortiert nach

FACTORS CONTRIBUTING TO PERITONEAL TISSUE REMODELING IN PERITONEAL DIALYSIS

Peritoneal dialysis international, 2009-11, Vol.29 (6), p.605-617

2009

Link zum Volltext

Verfügbarkeit prüfen

Higher plasma levels of von Willebrand factor and C-reactive protein during a peritoneal dialysis regimen with less glucose and glucose degradation products

Peritoneal dialysis international, 2013-03, Vol.33 (2), p.208-212

2013

Link zum Volltext

Verfügbarkeit prüfen

Pharmacologic Targets and Peritoneal Membrane Remodeling

Peritoneal dialysis international, 2014-01, Vol.34 (1), p.114-123

2014

Link zum Volltext

Verfügbarkeit prüfen

“NEPP” Peritoneal Dialysis Regimen Has Beneficial Effects on Plasma CEL and 3-DG, But Not Pentosidine, CML, and MGO

Peritoneal dialysis international, 2012-01, Vol.32 (1), p.45-54

2012

Link zum Volltext

Verfügbarkeit prüfen

A Peritoneal Dialysis Regimen Low in Glucose and Glucose Degradation Products Results in Increased Cancer Antigen 125 and Peritoneal Activation

Peritoneal dialysis international, 2012-05, Vol.32 (3), p.305-315

2012

Link zum Volltext

Verfügbarkeit prüfen

LONG-TERM INTERVENTION WITH HEPARINS IN A RAT MODEL OF PERITONEAL DIALYSIS

Peritoneal dialysis international, 2009-01, Vol.29 (1), p.26-35

2009

Link zum Volltext

Verfügbarkeit prüfen

Single exposure of mesothelial cells to glucose degradation products (GDPs) yields early advanced glycation end-products (AGEs) and a proinflammatory response

Peritoneal dialysis international, 2003-05, Vol.23 (3), p.213-221

2003

Link zum Volltext

Verfügbarkeit prüfen

Initiating capd with a regimen low in glucose and glucose degradation products, with icodextrin and amino acids (NEPP) is safe and efficacious

Peritoneal dialysis international, 2005-02, Vol.25 (3_suppl), p.S64-S68

2005

Link zum Volltext

Verfügbarkeit prüfen

Better preservation of the peritoneum in rats exposed to amino acid-based peritoneal dialysis fluid

Peritoneal dialysis international, 2005-01, Vol.25 (1), p.58-67

2005

Link zum Volltext

Verfügbarkeit prüfen

Increased leukocyte rolling in newly formed mesenteric vessels in the rat during peritoneal dialysis

Peritoneal dialysis international, 2002-11, Vol.22 (6), p.655-662

2002

Link zum Volltext

Verfügbarkeit prüfen

Intraperitoneal ciprofloxacin and rifampicin versus cephradine as initial treatment of (C)APD-related peritonitis: a prospective randomized multicenter comparison (CIPPER trial)

Peritoneal dialysis international, 2001-09, Vol.21 (5), p.480-486

2001

Link zum Volltext

Verfügbarkeit prüfen

Comparison of the AT1-receptor blockers candesartan, irbesartan and losartan for inhibiting renal microvascular constriction

Journal of the renin-angiotensin-aldosterone system, 2001-03, Vol.2 (1_suppl), p.S204-S210

2001

Link zum Volltext

Verfügbarkeit prüfen

Folic acid treatment of hyperhomocysteinemia in peritoneal dialysis patients: no change in endothelial function after long-term therapy

Peritoneal dialysis international, 1998-05, Vol.18 (3), p.282

1998

Link zum Volltext

Verfügbarkeit prüfen

Better preservation of the peritoneum in rats exposed to amino acid-based peritoneal dialysis fluid. Commentary

Peritoneal dialysis international, 2005, Vol.25 (1), p.58-67

2005

Link zum Volltext

Verfügbarkeit prüfen

Accumulation of omental mast cells during peritoneal dialysis

Peritoneal dialysis international, 2001-01, Vol.21 Suppl 3 (3_suppl), p.S373-376

2001

Link zum Volltext

Verfügbarkeit prüfen

1 – 15 von 15

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SeriePalliative Medicine

KollektionEZB Electronic Journals Library

KollektionSAGE Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(15)

Sprache

Englisch
(15)
Japanisch
(3)

Erscheinungsjahr

n.n

Kollektion

Zeitschrift / Serie

Menü

Weitere Dienste

Einstellungen

FACTORS CONTRIBUTING TO PERITONEAL TISSUE REMODELING IN PERITONEAL DIALYSIS

Higher plasma levels of von Willebrand factor and C-reactive protein during a peritoneal dialysis regimen with less glucose and glucose degradation products

Pharmacologic Targets and Peritoneal Membrane Remodeling

“NEPP” Peritoneal Dialysis Regimen Has Beneficial Effects on Plasma CEL and 3-DG, But Not Pentosidine, CML, and MGO

A Peritoneal Dialysis Regimen Low in Glucose and Glucose Degradation Products Results in Increased Cancer Antigen 125 and Peritoneal Activation

LONG-TERM INTERVENTION WITH HEPARINS IN A RAT MODEL OF PERITONEAL DIALYSIS

Single exposure of mesothelial cells to glucose degradation products (GDPs) yields early advanced glycation end-products (AGEs) and a proinflammatory response

Initiating capd with a regimen low in glucose and glucose degradation products, with icodextrin and amino acids (NEPP) is safe and efficacious

Better preservation of the peritoneum in rats exposed to amino acid-based peritoneal dialysis fluid

Increased leukocyte rolling in newly formed mesenteric vessels in the rat during peritoneal dialysis

Intraperitoneal ciprofloxacin and rifampicin versus cephradine as initial treatment of (C)APD-related peritonitis: a prospective randomized multicenter comparison (CIPPER trial)

Comparison of the AT1-receptor blockers candesartan, irbesartan and losartan for inhibiting renal microvascular constriction

Folic acid treatment of hyperhomocysteinemia in peritoneal dialysis patients: no change in endothelial function after long-term therapy

Better preservation of the peritoneum in rats exposed to amino acid-based peritoneal dialysis fluid. Commentary

Accumulation of omental mast cells during peritoneal dialysis

Aktive Filter

Suchergebnisse filtern